Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pain × Sugars × Clear all

Phase

Phase NA 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3 Breast Neoplasms 3 Neoplasms 2 Vomiting 1 Peripheral Nervous System Diseases 1 Periampullary Carcinoma Nos 1 Pediatric Crohn's disease 1 Pain 1 Nausea 1 Myasthenia Gravis 1 Memory Disorders 1 Leiomyoma 1 Hot Flashes 1 Fatigue 1 Cognitive Dysfunction 1 Cancer Pain 1 Anemia 1

Interventions

Fentanyl 7 Zoledronic Acid 6 Radiotherapy 6 Ibandronic Acid 6 Morphine 5 Ketamine 5 Hydromorphone 5 nabiximols 4 Tapentadol 4 Oxycodone 4 Analgesia 4 alvimopan 3 Lidocaine 3 Acupuncture Therapy 3 Acetaminophen 3 Tetrodotoxin 2 Ropivacaine 2 Gabapentin 2 Docetaxel 2 resiniferatoxin 1 oxycodone-acetaminophen 1 oxycodone naloxone combination 1 ixabepilone 1 cabozantinib 1 Triamcinolone Acetonide 1 Triamcinolone 1 Therapeutics 1 Taxes 1 Sugars 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00152854 2016-03-08

Acetaminophen for Cancer Pain

University Health Network, Toronto

Phase 3 Completed

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡